Dalton, Greiner, Hartman, Maher & Co’s Pfizer PFE Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-524,497	Closed	-$17M	–	184
2017 Q1	$17M	Sell	524,497 -2,045	-0.4%	-$64.5K	0.97%	43
2016 Q4	$16.2M	Sell	526,542 -21,004	-4%	-$641K	0.95%	43
2016 Q3	$17.6M	Sell	547,546 -208,282	-28%	-$6.96M	1.14%	19
2016 Q2	$25.2M	Sell	755,828 -106,345	-12%	-$3.39M	1.56%	4
2016 Q1	$24.2M	Sell	862,173 -407,502	-32%	-$11.6M	1.5%	5
2015 Q4	$38.9M	Sell	1,269,675 -134,983	-10%	-$4.25M	2.23%	2
2015 Q3	$41.9M	Sell	1,404,658 -122,999	-8%	-$3.94M	2.35%	2
2015 Q2	$48.6M	Sell	1,527,657 -26,535	-2%	-$865K	2.52%	1
2015 Q1	$51.3M	Sell	1,554,192 -26,218	-2%	-$834K	2.88%	1
2014 Q4	$46.7M	Buy	1,580,410 +212,467	+16%	+$6.09M	2.58%	1
2014 Q3	$38.4M	Buy	+1,367,943	New	+$38.4M	2.18%	1

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's PFE Position: Q2 2017 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Pfizer (PFE) in Q2 2017, closing a stake of 524,497 shares — an estimated $17M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in PFE in Q3 2014 and held it in 11 quarters. The position peaked at $51.3M in Q1 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Dalton, Greiner, Hartman, Maher & Co reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Dalton, Greiner, Hartman, Maher & Co sold 524,497 Pfizer shares in Q2 2017, an estimated $17M.
Dalton, Greiner, Hartman, Maher & Co first reported a position in Pfizer in Q3 2014 and held it in 11 quarters.
Dalton, Greiner, Hartman, Maher & Co's Pfizer position peaked at $51.3M in Q1 2015.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2017, filed 19 Jul 2017.